Meet Shivani Patel, M.D.
Shivani Patel, M.D.
Department of General Oncology, Division of Cancer Medicine
About Dr. Patel
I have the qualifications and experience to serve as an Investigator for the EDRN CVC. My areas of expertise include upper gastrointestinal malignancy (gastric, esophageal), hepatopancreaticobiliary malignancy, neuroendocrine tumors, sarcoma, and melanoma, and peritoneal surface malignancy and peritoneal carcinomatosis from GI or ovarian origin (HIPEC)…. My clinical research leadership includes serving as Contract PI for the clinical study Noncoding RNA Biomarkers for noninvasive and Early Detection of Pancreatic Cancer.
Present Title & Affiliation
Primary Appointment
Associate Professor (Joint appointment), Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2010 | University of Rochester School of Medicine and Dentistry, Rochester, New York, US, MD |
| 2006 | University of Rochester, Rochester, New York, US, Cell and Developmental Biology, Minor in Health and Society, BS |
Postgraduate Training
| 2020-2021 | Health Educators Fellowship Program, University of Texas McGovern Medical School, Houston, Texas |
| 2018-2018 | Project ECHO (Extension for Community Healthcare Outcomes) Training Certificate, MD Anderson, Houston, Texas |
| 2017-2018 | Graduate Certificate in Health Care Management, Rice University Jesse H. Jones Graduate School of Business, Houston, Texas |
| 2017-2017 | Harvard Global Health Delivery Certificate, Harvard Office of the Vice Provost for Advances in Learning, Online certificate course |
| 2015-2016 | Chief Fellow, Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas |
| 2013-2016 | Clinical Fellowship, Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas |
| 2010-2013 | Clinical Residency, Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas |
Licenses & Certifications
| 2016 | Medical Oncology, American Board of Internal Medicine |
| 2016 | Hematology, American Board of Internal Medicine |
| 2015 | Texas State Medical Board |
| 2013 | Internal Medicine, American Board of Internal Medicine |
Experience & Service
Other Professional Positions
LBJ GI Tumor Board Co-Chair, Lyndon B. Johnson Hospital, Houston, TX, 2020 - Present
LBJ Tumor Board Program Physician Champion, Lyndon B. Johnson Hospital, Houston, TX, 2020 - Present
LBJ GI/GU Tumor Board Chair, Lyndon B. Johnson, Houston, TX, 2019 - 2020
Extramural Institutional Committee Activities
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Associate Scientific Member, Institutional Review Board 1, The University of Texas MD Anderson Cancer Center, 2017 - 2020
Vice-Chair, Institutional Review Board 1, The University of Texas MD Anderson Cancer Center, 2000 - Present
Honors & Awards
| 2010 | AOA Medical Student Service Leadership Project Award |
Professional Memberships
Selected Presentations & Talks
Regional Presentations
- 2021. Development of a Tumor Board Primer for Medical Oncology Fellows. Conference. UT Health. Virtual, US.
- 2015. New Clinical Considerations for the Management of Malignant Extraadrenal Paraganglioma, Poster Presentation. Conference. Texas Society of Clinical Oncology. Austin, TX, US.
- 2012. Prophylaxis Provoking Platelet Aggregation and Phlegmasia. Conference. American College of Physicians North Texas. Dallas, TX, US.
- 2007. Time Motion Study of Emergency Pharmacist Activity in an Academic Emergency Department. Conference. University of Rochester. Rochester, NY, US.
National Presentations
- 2013. Comparison of Medical Oncologists’ Approach to Non-Small Cell Lung Cancer Patients Compared with Breast Cancer. Conference. Poster presentation, American Society of Clinical Oncology Annual Meeting. Chicago, IL, US.
- 2012. Lupus Anticoagulant Screening Tests have Best Performance Characteristics for the Diagnosis of Antiphospholipid Syndrome. Conference. Poster presentation, 2012 Thrombosis & Hemostasis Summit of North America. Chicago, IL, US.
- 2010. A Retrospective Study of Central Nervous System Metastases in Esophageal Carcinoma. Conference. Poster Presentation, 2010 American Academy of Neurology Annual Meeting Poster Symposium. Toronto, CA.
Grant & Contract Support
| Date: | 2022 - 2027 |
| Title: | Clinical Validation Center for Early Detection of Pancreatic Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 2U01CA200468-06 |
Selected Publications
Peer-Reviewed Articles
- Denu RA, McDermott JJ, Patel SC, Patel T, Dahr SS. Vogt-Koyanagi-Harada-Like Uveitis Secondary to Pembrolizumab in Metastatic Gastric Cancer: A Case Report and Review of the Literature. Case Rep Oncol 17(1):1071-1086, 2024. e-Pub 2024. PMID: 39474530.
- Bagley, AF, Ludmir, EB, Maitra, A, Minsky, B, Smith, GL, Das, P, Koong, A, Holliday, EB, Taniguchi, C, Katz, MH, Tamm, EP, Wolff, RA, Overman, MJ, Patel, SC, Kim, M, Tzeng, CD, Ikoma, N, Bhutani, M, Koay, EJ. NBTXR3, a first-in-class radio enhancer for pancreatic ductal adenocarcinoma. Clinical and Translational Radiation Oncology 33:66-69, 2022. e-Pub 2022. PMID: 35097226.
- Patel S, Dowell J. Modern Management of Malignant Pleural Mesothelioma. Lung Cancer: Targets and Therapy 7:63-72, 2016. e-Pub 2016.
Other Articles
- Bagley AF, Ludmir EB, Maitra A, Minsky BD, Smith GL, Das P, Koong A, Holliday EB, Taniguchi CM, Katz MH, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJ NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. Clinical and Translational Radiation Oncology 33:66-69, 2022.
Abstracts
- Patel S, Hamman H, Patel P, Schiller J. Comparison of Medical Oncologists' Approach to Non-Small Cell Lung Cancer Patients Compared with Breast Cancer. J Clin Oncol 31(suppl;abstr 6601), 2013. e-Pub 2013.
- Patel S, Delrie R, Tam K, Abou Zahr A, Weil A, Tsai J, Frenkel E, Sarode R, Shen Y. Lupus Anticoagulant Screening Tests have Best Performance Characteristics for the Diagnosis of Antiphospholipid Syndrome. (2012), Proceedings of the Thrombosis and Hemostasis summit of North America 2012: Research abstracts. Am. J. Hematol 87:S146–S200, 2012. e-Pub 2012.
Patient Reviews
CV information above last modified July 22, 2026